Rhenovia Pharma Announces Development of First Computer Simulator

Developed within the context of the RHENEPI consortium, this computer simulator opens up new possibilities for research into new treatments for epilepsy and identification of the convulsion risks associated with candidate drugs or environmental factors.

Access to this article and other content is for registered users.

Join the Technology Networks Community

Access to the latest scientific news, products and research through Technology Networks